NGS · ASX

Nutritional Growth Solutions Ltd. (ASX:NGS)

AU$0.023

 0.0 (0.0%)
ASX:Live
08/05/2025 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

NGS Overview

NGS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

NGS Price Chart

Key Stats

Market Cap

AU$2.89M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.06

Trade Value (12mth)

AU$1,605.00

1 week

-14.81%

1 month

-23.33%

YTD

-48.89%

1 year

-42.5%

All time high

3.80

Key Fundamentals

EPS 3 yr Growth

-89.70%

EBITDA Margin

-112.90%

Operating Cashflow

-$3m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-36.90

Quick Ratio

0.10

Other Data

Shares on Issue (Fully Dilluted)

127m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

NGS Announcements

Latest Announcements

Date Announcements

30 April 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 April 25

Commitments Received For $1M Convertible Note Placement

×

Commitments Received For $1M Convertible Note Placement

28 April 25

Proposed issue of securities - NGS

×

Proposed issue of securities - NGS

23 April 25

Trading Halt

×

Trading Halt

04 April 25

Appointment of new CFO

×

Appointment of new CFO

31 March 25

Annual Report to shareholders

×

Annual Report to shareholders

31 March 25

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

11 March 25

NGS expands distribution into U.S. Pharmacy channel with CVS

×

NGS expands distribution into U.S. Pharmacy channel with CVS

04 March 25

NGS expands retail footprint with Wakefern

×

NGS expands retail footprint with Wakefern

03 March 25

Final Director's Interest Notice - Peter Osborne

×

Final Director's Interest Notice - Peter Osborne

10 February 25

Appointment of Independent Chair

×

Appointment of Independent Chair

31 January 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

24 January 25

Change of Director's Interest Notice - Steve Turner

×

Change of Director's Interest Notice - Steve Turner

14 January 25

Change of Local Agent

×

Change of Local Agent

14 January 25

Application for quotation of securities - NGS

×

Application for quotation of securities - NGS

14 January 25

Cleansing Notice

×

Cleansing Notice

13 December 24

Trading Update

×

Trading Update

10 December 24

NGS Announces Transition in Leadership

×

NGS Announces Transition in Leadership

10 December 24

Final Director's Interest Notice

×

Final Director's Interest Notice

06 November 24

Response to ASX Query Letter

×

Response to ASX Query Letter

04 November 24

Becoming a substantial holder

×

Becoming a substantial holder

31 October 24

Notification regarding unquoted securities - NGS

×

Notification regarding unquoted securities - NGS

29 October 24

Application for quotation of securities - NGS

×

Application for quotation of securities - NGS

29 October 24

Cleansing Notice

×

Cleansing Notice

23 October 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NGS Shortsell

Frequently Asked Questions

The current share price of Nutritional Growth Solutions Ltd. (NGS:ASX) is AU$0.023.
The 52-week high share price for Nutritional Growth Solutions Ltd. (NGS:ASX) is AU$0.06.
The 52-week low share price for Nutritional Growth Solutions Ltd. (NGS:ASX)? is AU$0.02.
Nutritional Growth Solutions Ltd. (NGS:ASX) does not pay a dividend.
Nutritional Growth Solutions Ltd. (NGS:ASX) does not pay a dividend.
Nutritional Growth Solutions Ltd. (NGS:ASX) has a franking level of 0.0%.
Nutritional Growth Solutions Ltd. (NGS:ASX) is classified in the Healthcare.
The current P/E ratio for Nutritional Growth Solutions Ltd. (NGS:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.